Article in Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Luke BransomDepartment of Pharmacology, Penn State University College of Medicine, Hershey PA 17033, United States.
Ava P BassettDepartment of Pharmacology, Penn State University College of Medicine, Hershey PA 17033, United States.
Mi ZhouDepartment of Pharmacology, Penn State University College of Medicine, Hershey PA 17033, United States; Department of Neurology, Penn State University College of Medicine, Hershey, PA 17033, United States.
Jack X CiminoDepartment of Pharmacology, Penn State University College of Medicine, Hershey PA 17033, United States.
Richard B MailmanDepartment of Pharmacology, Penn State University College of Medicine, Hershey PA 17033, United States; Department of Neurology, Penn State University College of Medicine, Hershey, PA 17033, United States.
Yang YangDepartment of Pharmacology, Penn State University College of Medicine, Hershey PA 17033, United States. Electronic address: yangyang@psu.edu.
Funding
Discovery of functionally selective dopamine ligands for age-related cognitive declineRF1AG071675 · NIA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI DOKHOLYAN, NIKOLAY, MAILMAN, RICHARD B · 2021 to 2021
$1.5M
Discovery of functionally selective dopamine ligands for age-related cognitive declineR01AG071675 · NIA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI DOKHOLYAN, NIKOLAY, MAILMAN, RICHARD B · 2024 to 2025
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.